These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2194587)

  • 21. Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis.
    Saglio G; Pane F; Gottardi E; Frigeri F; Buonaiuto MR; Guerrasio A; de Micheli D; Parziale A; Fornaci MN; Martinelli G; Salvatore F
    Blood; 1996 Feb; 87(3):1075-80. PubMed ID: 8562932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to Abl and Bcr proteins.
    Talpaz M; Qiu X; Cheng K; Cortes JE; Kantarjian H; Kurzrock R
    Leukemia; 2000 Sep; 14(9):1661-6. PubMed ID: 10995014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-detection of chimeric bcr/abl (target) and beta-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction.
    Wisniewski D; Strife A; Clarkson B
    Leuk Res; 1991; 15(9):867-74. PubMed ID: 1921462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias.
    Honda H; Oda H; Suzuki T; Takahashi T; Witte ON; Ozawa K; Ishikawa T; Yazaki Y; Hirai H
    Blood; 1998 Mar; 91(6):2067-75. PubMed ID: 9490692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemias.
    Dhingra K; Talpaz M; Riggs MG; Eastman PS; Zipf T; Ku S; Kurzrock R
    Blood; 1991 Jan; 77(2):238-42. PubMed ID: 1985690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
    Campbell ML; Li W; Arlinghaus RB
    Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
    Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
    Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl.
    Seo S; Nakamoto T; Takeshita M; Lu J; Sato T; Suzuki T; Kamikubo Y; Ichikawa M; Noda M; Ogawa S; Honda H; Oda H; Kurokawa M
    Cancer Sci; 2011 Dec; 102(12):2109-17. PubMed ID: 21848808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia.
    Diamond J; Goldman JM; Melo JV
    Blood; 1995 Apr; 85(8):2171-5. PubMed ID: 7718887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
    Akashi K; Taniguchi S; Nagafuji K; Harada M; Shibuya T; Hayashi S; Gondo H; Niho Y
    Leuk Res; 1993 Jul; 17(7):549-55. PubMed ID: 8326735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BCR/ABL hybrid gene.
    Groffen J; Heisterkamp N
    Baillieres Clin Haematol; 1987 Dec; 1(4):983-99. PubMed ID: 3332859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. bcr rearrangement and C-abl gene expression in Ph1-positive hybrid acute leukemia with simultaneous proliferation of lymphoid and myeloid blasts.
    Okabe M; Oita M; Kunieda Y; Matsuura J; Sakurada K; Matsushima S; Kakinuma M; Miyazaki T
    Blut; 1989 May; 58(5):241-6. PubMed ID: 2655744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region.
    ar-Rushdi A; Negrini M; Kurzrock R; Huebner K; Croce CM
    Oncogene; 1988 Apr; 2(4):353-7. PubMed ID: 3283653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship between the persistence of the BCR/ABL gene and relapse in adult patients with acute lymphoblastic leukemia].
    Anguita E; Villegas A; González FA; del Potro E; Martínez R; Alvarez A; Díaz-Mediavilla J; Ferro MT; Espinós D
    Med Clin (Barc); 1999 Apr; 112(13):481-4. PubMed ID: 10353112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of herbimycin A, an antagonist of tyrosine kinase, on bcr/abl oncoprotein-associated cell proliferations: abrogative effect on the transformation of murine hematopoietic cells by transfection of a retroviral vector expressing oncoprotein P210bcr/abl and preferential inhibition on Ph1-positive leukemia cell growth.
    Okabe M; Uehara Y; Miyagishima T; Itaya T; Tanaka M; Kuni-Eda Y; Kurosawa M; Miyazaki T
    Blood; 1992 Sep; 80(5):1330-8. PubMed ID: 1515646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
    de Jong R; van Wijk A; Haataja L; Heisterkamp N; Groffen J
    J Biol Chem; 1997 Dec; 272(51):32649-55. PubMed ID: 9405482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
    Melo JV; Myint H; Galton DA; Goldman JM
    Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
    He Y; Wertheim JA; Xu L; Miller JP; Karnell FG; Choi JK; Ren R; Pear WS
    Blood; 2002 Apr; 99(8):2957-68. PubMed ID: 11929787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.